Repligen
RGEN
#1861
Rank
โ‚น980.87 B
Marketcap
โ‚น15,344
Share price
-2.75%
Change (1 day)
11.82%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2026 (TTM): -โ‚น21.12

According to Repligen 's latest financial reports the company's current EPS (TTM) is -โ‚น18.53. In 2025 the company made an earnings per share (EPS) of โ‚น80.61 an increase over its 2024 EPS that were of -โ‚น47.26.

EPS history for Repligen from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น21.12-126.2%
2025โ‚น80.61-270.59%
2024-โ‚น47.26-168%
2023โ‚น69.50-77.68%
2022โ‚น311.3443.59%
2021โ‚น216.82105.26%
2020โ‚น105.63153.33%
2019โ‚น41.7018.42%
2018โ‚น35.21-47.95%
2017โ‚น67.64108.57%
2016โ‚น32.4320.69%
2015โ‚น26.8716%
2014โ‚น23.17-48.98%
2013โ‚น45.406.52%
2012โ‚น42.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น65.79-455.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น1,760-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น808.92-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น418.82-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น35.21 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น140.84 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น645.84-3,585.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น108.41-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-โ‚น8.34-55.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น94.51-610.00%๐Ÿ‡บ๐Ÿ‡ธ USA